93.0 ± 13.0, p = 0.14), and plasma biomarker levels including NfL and GFAP ( p = 0.23 and 0.15, respectively) were all numerically higher in the ARIA group; however, these differences did not reach statistical significance.
← all excerpts
Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study.
2
—
—
The sentences
Also, there was a suggestive trend between ARIA-E and the number of APOE ε4 alleles.